BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, February 16, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 31, 2020

View Archived Issues

GNOS-PV02 vaccine to be evaluated in patients with HCC

Read More

AI-generated compound begins phase I study in Japan for obsessive-compulsive disorder

Read More

Inovio and Beijing Advaccine collaborate to advance new vaccine against new coronavirus in China

Read More

BREEZE-AD5 phase II study of baricitinib in AD meets primary endpoint

Read More

German Medicines Agency approves phase II study of FOL-005

Read More

Kedrion Biopharma completes enrollment in phase III CARES10 study

Read More

Cerevel starts dosing volunteers in phase I study of CVL-936

Read More

First patient dosed in phase Ib study of GMI-1359 in breast cancer

Read More

FDA accepts IND application for FS-120 bispecific antibody

Read More

BBI-608 plus pembrolizumab shows encouraging antitumor activity in mCRC

Read More

Magrolimab plus cetuximab as a promising immunotherapeutic treatment regimen in CRC

Read More

Phase II study of PBI-05204 in mPDA does not meet primary endpoint

Read More

Fimbrion Therapeutics and GlaxoSmithKline describe Escherichia coli FimH inhibitors

Read More

New high affinity nerve growth factor receptor inhibitors identified at Medshine Discovery

Read More

Naltrexone prodrugs synthesized at Alkermes

Read More

Novartis patents compounds for IKZF2-dependent disease

Read More

Recordati Industria Chimica e Farmaceutica discovers P2X3 and P2X2/3 antagonists

Read More

"Confused and disorganized": Stress, identity crises part of growing up -- for organoids

Read More

RC-48-ADC shows meaningful benefit in phase I solid tumors trial

Read More

CEACAM6 levels linked to sensitivity to pelareorep in pancreatic adenocarcinoma

Read More

IRICoR, UdeM and Medigene establish collaboration on novel cancer antigens

Read More

Phase I study of Rani's orally delivered octreotide meets primary and secondary endpoints

Read More

Fuzionaire Diagnostics establishes new research collaboration in neurodegeneration

Read More

IND clearance for VistaGen's AV-101 for levodopa-induced dyskinesia in Parkinson's

Read More

Immune Response BioPharma plans IND filing for new SARS/coronavirus vaccine

Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Woman and 3D brain

    Astellas’ ASP-2246 shows promise in stroke management

    BioWorld Science
    Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing